Jiang G - Search Results

1

Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial.

Meng X, Wu T, Hong Y, Fan Q, Ren Z, Guo Y, Yang X, Shi P, Yang J, Yin X, Luo Z, Xia J, Zhou Y, Xu M, Liu E, Jiang G, Li S, Zhao F, Ma C, Ma C, Hou Z, Li J, Wang J, Wang F. Meng X, et al. Among authors: jiang g. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):245-253. doi: 10.1016/S2468-1253(21)00378-2. Epub 2022 Jan 6. Lancet Gastroenterol Hepatol. 2022. PMID: 34998471 Clinical Trial.

2

Epithelioid inflammatory myofibroblastic sarcoma with recurrence after extensive resection: significant clinicopathologic characteristics of a rare aggressive soft tissue neoplasm.

Zhou J, Jiang G, Zhang D, Zhang L, Xu J, Li S, Li W, Ma Y, Zhao A, Zhao Z. Zhou J, et al. Among authors: jiang g. Int J Clin Exp Pathol. 2015 May 1;8(5):5803-7. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191301 Free PMC article.

3

WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.

Jiang G, Lin J, Wang W, Sun M, Chen K, Wang F. Jiang G, et al. Genet Test Mol Biomarkers. 2017 Feb;21(2):74-79. doi: 10.1089/gtmb.2016.0162. Epub 2017 Jan 4. Genet Test Mol Biomarkers. 2017. PMID: 28051879

4

A Case of Primary Resistance to Geﬁtinib due to Novel Deletion-Insertion Mutation of EGFR Exon 19 in NSCLC.

Xia P, Liu E, Li P, Li W, Jiang G. Xia P, et al. Among authors: jiang g. J Thorac Oncol. 2019 Jun;14(6):e117-e119. doi: 10.1016/j.jtho.2019.01.033. J Thorac Oncol. 2019. PMID: 31122561 Free article. No abstract available.

5

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma.

Zhang L, Li P, Liu E, Xing C, Zhu D, Zhang J, Wang W, Jiang G. Zhang L, et al. Among authors: jiang g. Cancer Cell Int. 2020 Aug 10;20:386. doi: 10.1186/s12935-020-01480-9. eCollection 2020. Cancer Cell Int. 2020. PMID: 32831646 Free PMC article.

6

Implication of Microsatellite Instability in Chinese Cohort of Human Cancers.

Cui M, Li P, Mao Y, Zhang L, Xia P, Liu E, Wang W, Zhang J, Jiang G, Li W. Cui M, et al. Among authors: jiang g. Cancer Manag Res. 2020 Oct 19;12:10287-10295. doi: 10.2147/CMAR.S274187. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116883 Free PMC article.

7

RNA sequencing reveals the expression profiles of circRNA and identifies a four-circRNA signature acts as a prognostic marker in esophageal squamous cell carcinoma.

Wang W, Zhu D, Zhao Z, Sun M, Wang F, Li W, Zhang J, Jiang G. Wang W, et al. Among authors: jiang g. Cancer Cell Int. 2021 Mar 4;21(1):151. doi: 10.1186/s12935-021-01852-9. Cancer Cell Int. 2021. PMID: 33663506 Free PMC article.

8

Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers.

Xia P, Zhang L, Li P, Liu E, Li W, Zhang J, Li H, Su X, Jiang G. Xia P, et al. Among authors: jiang g. J Transl Med. 2021 Jul 16;19(1):308. doi: 10.1186/s12967-021-02982-4. J Transl Med. 2021. PMID: 34271921 Free PMC article.

9

GNAQ T96S mutation abrogates the ability of wild-type GNAQ to induce apoptosis by phosphorylating annexin A2 in natural killer/T cell lymphoma.

Zhao W, Zhang M, Wang G, Liu E, Jiang G, Zhang Y, Zhang D, Jian X, Zhao H, Zhang C, Li W. Zhao W, et al. Among authors: jiang g. Cancer Sci. 2022 Jul;113(7):2288-2296. doi: 10.1111/cas.15333. Epub 2022 May 13. Cancer Sci. 2022. PMID: 35293080 Free PMC article.

10

Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial.

Jin S, Zhao R, Zhou C, Zhong Q, Shi J, Su C, Li Q, Su X, Chi H, Lu X, Jiang G, Chen R, Han J, Jiang M, Qiao S, Liu J, Song M, Song L, Du Y, Chang Z, Wang M, Dong M, Zhong Y, Yu P, Zhang X, Zong H. Jin S, et al. Among authors: jiang m, jiang g. Int J Cancer. 2023 Apr 15;152(8):1648-1658. doi: 10.1002/ijc.34372. Epub 2022 Dec 1. Int J Cancer. 2023. PMID: 36444498 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,498 results

Search Page

Filters